Periodontitis and ACPA positive Arthralgia*s; a link by protein citrullinatio
- Conditions
- parodontitisRA risk group or pre-RA group1000381610004018
- Registration Number
- NL-OMON35274
- Lead Sponsor
- niversitair Medisch Centrum Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 200
Patients who are ACPA and or RF positive and who have arthralgia*s, aged > 18 years.
Fullfilling ACR criteria for RA.
Exclusion criteria (according to the SENIEUR protocol 1984)
1. Infection other than periodontitis.
2. Inflammation other than periodontitis (RA, Crohn*s disease, collagen-vascular diseases).
3. Malignancy, past or present.
4. Other conditions which influence the immune system: diabetes, active thyroid disease, myocardial infarction, stroke or recanalisation of the femoral arteries for claudication <6 months prior to the study.
5. Pregnancy including a 6-months post-partum period as well as breastfeeding.
6. Malnutrition.
7. Alcoholism and drug abuse.
8. Pharmacological interference: prescribed medication for the treatment of a defined disease, use of corticosteroids >10mg/day, antibiotic use during 3 months prior to the study.
9. Periodontal treatment prior to the study.
10. Edentulism.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Clinical parameters:<br /><br>Disease Activity Score 28 joint count (DAS28 and DAS44)<br /><br>Periodontitis: Periodontal Inflamed Surface Area (PISA (Nesse et al. 2008) and<br /><br>extent of alveolar bone loss measured on an panoramic radiograph.<br /><br>Biomarkers: ACPA titer and anti-Pg titer </p><br>
- Secondary Outcome Measures
Name Time Method <p>Leukocyte count, CRP and ESR.<br /><br>Presence of citrullinated proteins, ACPA and expression of PAD-2 and -4 enzymes<br /><br>in GCF, SF and tissue, cell types present in tissue.<br /><br>Presence of P. gingivalis in subgingival plaque.<br /><br>Presence of HLA-DRB1* shared epitope (SE) alleles.<br /><br>Lymphocyte subsets with an emphasis on CD161 staining </p><br>